|
|
|
|
Welcome to the CVBF newsletter!
May the spirit of the Christmas fill your home with peace, joy and love.
CVBF wishes you all merry Christmas and Happy new year!
|
|
| Save the date – TEDDY General Assembly, January 14th, 2018, Rome
TEDDY – European Network of Excellence for Paediatric Clinical Research announces the Scientific Meeting and General Assembly entitled “A new phase for paediatric clinical research: a play role for TEDDY?”, that will be held in January 14th, 2018 at Hotel Ripa Via degli Orti di Trastevere, 3 Rome – Italy.
|
|
|
| Save the date – ID-EPTRI Kick-off-meeting, January 15th-16th, 2018, Rome
The recently EU-funded project ID-EPTRI (European Paediatric Translational Research Infrastructure), aimed to design a new Research Infrastructure (RI) in Europe completely dedicated to Paediatrics will be launched in January 15th-16th 2018, at Ministry of Education, Universities and Research Sala della Comunicazione Viale Trastevere, 76/a Rome, Italy. |
|
|
| EU H2020 “SPASD – Strengthening the Capacity of Professionals Working in Schools with Children and Young People with ASD” Project Kick-off Meeting.
Bucharest, November 30th, 2017. The new European project SPASD – Strengthening the Capacity of Professionals Working in Schools with Children and Young People with Autism Spectrum Disorder (ASD) – was officially kicked off in Bucharest, Romania, on November 30th, 2017.
|
|
|
| CVBF will be partner in two projects recently funded by the AIFA 2016 Call
The Italian Medicines Agency (AIFA) announced the conclusion of the double-stage selection process of the AIFA 2016 call. Among the 343 clinical protocols submitted and considered eligible, 40 projects have been approved for a total value of funding of 31,294,724 euro. CVBF will take part to two of the funded clinical studies.
|
|
|
| An innovative approach for the patient involvement in the paediatric clinical research: the role of YPAGs
Over the last years, a Europe-wide trend towards a patient-focused approach and the involvement of patients is developing and is influencing the decision-making process related to clinical research. Patients involvement in paediatric clinical research is recognised as an important added value at European and international level and an essential contribution to clinical research.
|
|
|
| ICH-GOOD CLINICAL PRACTICE (GCP) TRAINING COURSE
The e-learning “ICH-Good Clinical Practice (GCP) Training Course”, promoted by Consorzio per Valutazioni Biologiche e Farmacologiche in the framework of the GAPP project, meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified as necessary to enable mutual recognition of GCP training among trial sponsors as recognised by TransCelerate BioPharma.
|
|
|
| THE 4TH EDITION OF RE(ACT) CONGRESS
From 7th to 10th March 2018, The International Congress on Research of Rare and Orphan Diseases will take place at the Istituto Ortopedico Rizzoli in Bologna, Italy and will bring together world leaders and young scientist, who will share and discuss the results of their studies and cutting-edge research. It will be an occasion to exchange ideas and stimulate learning, networking and interdisciplinary collaboration.
|
|
|
| Launch of the Parliamentary Advocates for Rare Diseases
On 17th October 2017, the Parliamentary Advocates for Rare Diseases, a network of European and national members of parliament advocating to improve the lives of people living with a rare disease, was launched by EURORDIS, the European Organization for Rare Diseases, in occasion of the event “Juggling Care and Daily Life: the Balancing Act of the Rare Diseases Community”.
|
|
|
| EMA: Brexit update and adoption of work programme for 2018
The last press release published by EMA (European Medicines Agency) on December 15th, 2017, reports some important highlights from the Management Board meeting about Brexit preparation and the adoption of the work programme for 2018.
|
|
|
|
|
|
|
|
|
|